Evidence supporting the use of: Vitamin E (tocopheryl succinate)
For the health condition: Macular Degeneration

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Vitamin E, including its form as tocopheryl succinate, has been studied for its potential role in supporting or slowing the progression of age-related macular degeneration (AMD). The scientific rationale comes largely from its antioxidant properties; oxidative stress is thought to contribute to retinal damage in AMD. The most significant evidence comes from the Age-Related Eye Disease Study (AREDS), a large, multicenter, randomized clinical trial sponsored by the National Eye Institute. The AREDS formulation included vitamin E (as alpha-tocopherol, not specifically tocopheryl succinate), vitamin C, beta-carotene, zinc, and copper. Results showed that this combination reduced the risk of progression to advanced AMD by about 25% in individuals with intermediate or advanced disease in one eye. However, vitamin E alone has not been shown to be effective for preventing or treating AMD, and studies evaluating vitamin E monotherapy have generally found no significant benefit. The evidence for tocopheryl succinate specifically is limited, as most studies use alpha-tocopherol.

In summary, while vitamin E is part of a scientifically validated supplement regimen for certain patients with AMD, its use is supported only in combination with other antioxidants and minerals, not as a standalone therapy. The evidence level is moderate (3/5) due to its inclusion in the AREDS formula, but not strong for vitamin E alone or for the succinate ester specifically.

More about Vitamin E (tocopheryl succinate)
More about Macular Degeneration

Products containing Vitamin E (tocopheryl succinate)

We currently have no products on Caring Sunshine that contain this ingredient.